PharmAthene (PIP) Posts Q2 EPS Loss of $0.05, Revenues Miss Consensus
Tweet
Share
E-mailGet Alerts PIP Hot Sheet
Price: $0.65 --0%
Financial Fact:
Research and development: 1.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 1.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
PharmAthene, Inc. (NYSE: PIP) reported Q2 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $6.43 million versus the consensus estimate of $6.75 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
